Voyager Therapeutics Inc. on Friday registered with the Securities and Exchange Commission for an initial public offering of up to $86.3 million. Voyager reported a loss of $18.5 million and collaboration revenue of $7.5 million in the first six months of 2015. Its biggest shareholder with a 52.6% stake is Third Rock Ventures L.P., according to its SEC filing. The company plans to list its shares on the Nasdaq Global Market under the ticker “VYGR.”
Help employers find you! Check out all the jobs and post your resume.
